Safety and Immunogenicity of Typhax, a Typhoid Vaccine
Clinical trial NCT03926455 · COMPLETED
Trial details
- NCT number
- NCT03926455
- Sponsor
- Matrivax Research and Development Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-28
- Primary completion
- 2017-02-15
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.